Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ludovic Kambou"'
Autor:
Sylvain F. Nkwenkeu, Mohamed F. Jalloh, Jenny A. Walldorf, Robert L. Zoma, Felix Tarbangdo, Soukeynatou Fall, Sansan Hien, Roland Combassere, Cesaire Ky, Ludovic Kambou, Alpha Oumar Diallo, Akshaya Krishnaswamy, Flavien H. Aké, Cynthia Hatcher, Jaymin C. Patel, Isaïe Medah, Ryan T. Novak, Terri B. Hyde, Heidi M. Soeters, Imran Mirza
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was schedul
Externí odkaz:
https://doaj.org/article/9e04871cd0ac4522b05652eb25d342c5
Autor:
Ryan T. Novak, Heidi M Soeters, Cynthia Hatcher, Jenny A. Walldorf, Alpha Oumar Diallo, Isaïe Medah, Robert L. Zoma, Jaymin C. Patel, Terri B. Hyde, Ludovic Kambou, Félix Tarbangdo, Brooke Noel Aksnes, Mohamed F Jalloh, Imran Mirza, Sansan Hien, Sylvain F. Nkwenkeu, Soukeynatou Fall, Flavien Aké, Cesaire Ky
Publikováno v:
Vaccine
Highlights • Caregivers were motivated to vaccinate their children against measles and meningitis. • Motivations were driven by vaccine communication and perceived disease protection. • Health workers were trusted sources of vaccine information
Autor:
Jenny A. Walldorf, Isaïe Medah, Akshaya Krishnaswamy, Terri B. Hyde, Hermann Badolo, Robert L. Zoma, Guetawendé Sawadogo, Moumouni Nikiema, Ludovic Kambou, Sylvain F. Nkwenkeu, Félix Tarbangdo, Imran Mirza, Heidi M Soeters, Alpha Oumar Diallo, Cynthia Hatcher, Ange B Bationo, Jaymin C. Patel, Arnaud Ouedraogo, Ryan T. Novak, Flavien Aké, Romeo Ouili, Kathleen Wannemuehler
Publikováno v:
The Journal of Infectious Diseases. 220:S233-S243
Background After successful meningococcal serogroup A conjugate vaccine (MACV) campaigns since 2010, Burkina Faso introduced MACV in March 2017 into the routine Expanded Programme for Immunization schedule at age 15–18 months, concomitantly with se
Autor:
Sara Tartof, Amanda Cohn, Félix Tarbangdo, Mamoudou H Djingarey, Nancy Messonnier, Thomas A Clark, Jean Ludovic Kambou, Ryan Novak, Fabien V K Diomandé, Isaïe Medah, Michael L Jackson
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 12, p e0190188 (2017)
PLoS ONE, Vol 12, Iss 12, p e0190188 (2017)
The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed an age-structured mathematical model of MenA transmission, colonization, and disease in th
Autor:
Leonard W. Mayer, Stacey W. Martin, Tiga F. Tarbangdo, Ryan T. Novak, Fenella Avokey, Clement Lingani, Cynthia Hatcher, Lassana Sangaré, Sylvestre R. M. Tiendrebéogo, Jean Ludovic Kambou, F. Marc LaForce, Nancy E. Messonnier, Fabien Diomandé, Thomas A. Clark, Rasmata Ouédraogo-Traoré, Mamoudou Harouna Djingarey
Publikováno v:
The Lancet Infectious Diseases. 12:757-764
An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA-TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the first country to implement a national prevention campai
Autor:
Isaïe Medah, Sarah A. Meyer, Jean Ludovic Kambou, Amadou Fall, Issaka Yaméogo, Kathleen Wannemuehler, Thomas A. Clark, James L. Goodson, Nancy E. Messonnier, Brendan Flannery, Ryan T. Novak, Mamoudou Harouna Djingarey, Amanda C. Cohn, Fabien Diomandé
A new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1-29 year olds was conducted in Bur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1cc31cd1f31d2404bf3d85aaf6557e0
https://europepmc.org/articles/PMC5755366/
https://europepmc.org/articles/PMC5755366/
Autor:
Ludovic Kambou, Michèle Dramaix-Wilmet, Stéphane Hugonnet, Frank Drabo, Judith E. Mueller, Philippe Donnen, Haoua Tall
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2012, 12, pp.2. ⟨10.1186/1471-2334-12-2⟩
BMC Infectious Diseases, Vol 12, Iss 1, p 2 (2012)
BMC infectious diseases, 12
BMC Infectious Diseases, BioMed Central, 2012, 12, pp.2. ⟨10.1186/1471-2334-12-2⟩
BMC Infectious Diseases, Vol 12, Iss 1, p 2 (2012)
BMC infectious diseases, 12
Background: The epidemiology of meningococcal meningitis in the African meningitis belt is characterised by seasonality, localised epidemics and epidemic waves. To facilitate research and surveillance, we aimed to develop a definition for localised e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc72741c2b5691308a9868ba4e8b13bb
https://hal.ehesp.fr/hal-03034603
https://hal.ehesp.fr/hal-03034603
Autor:
Aly Drabo, Judith E. Mueller, Tsidi Agbeko Tamekloe, Bradford D. Gessner, Berthe Marie Njanpop-Lafourcade, Macaire S. Ouedraogo, Philippe Jaillard, Oumarou Sanou, Seydou Yaro, Kossi Badziklou, Isabelle Delrieu, Jean Ludovic Kambou, Haoua Tall
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2011, 6 (5), pp.e19513. ⟨10.1371/journal.pone.0019513⟩
PLoS ONE, Vol 6, Iss 5, p e19513 (2011)
PLoS ONE, Public Library of Science, 2011, 6 (5), pp.e19513. ⟨10.1371/journal.pone.0019513⟩
PLoS ONE, Vol 6, Iss 5, p e19513 (2011)
International audience; Serogroup X meningococci (NmX) historically have caused sporadic and clustered meningitis cases in sub-Saharan Africa. To study recent NmX epidemiology, we analyzed data from population-based, sentinel and passive surveillance
Autor:
Nancy E. Messonnier, Jean Ludovic Kambou, Michael L. Jackson, Thomas A. Clark, Isaïe Medah, Félix Tarbangdo, Sara Y. Tartof, Fabien Diomandé, Mamoudou Harouna Djingarey, Amanda C. Cohn, Ryan T. Novak
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63605 (2013)
PLoS ONE
PLoS ONE
Objective The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed an age-structured mathematical model of MenA transmission, colonization, and dis
Autor:
Jessica R. MacNeil, Isaïe Medah, Daouda Koussoubé, Ryan T. Novak, Amanda C. Cohn, Fabien V.K. Diomandé, Denis Yelbeogo, Jean Ludovic Kambou, Tiga F. Tarbangdo, Rasmata Ouédraogo-Traoré, Lassana Sangaré, Cynthia Hatcher, Jeni Vuong, Leonard W. Mayer, Mamoudou H. Djingarey, Thomas A. Clark, Nancy E. Messonnier
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 402-407 (2014)
In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a n
Externí odkaz:
https://doaj.org/article/721d162d924544658a40e15eafaddf31